Guest Profile

Dr. Geert Vanden Bossche

Dr. Geert Vanden Bossche
Dr. Geert Vanden Bossche

Scan QR code for the link to this page.

Creative thinker, innovator, entrepreneur and problem solver always open to new consultancy or career opportunities in the field of Vaccines, Life Sciences and/ or Global Health to deliver solutions to unmet medical needs.

Linked-In  Bio: click for my full CV


Dr. Geert Vanden Bossche, PhD, DVM

My work and supportive advice are driven by a relentless passion to help bridge the gap between research and enterprise and to translate scientific breakthrough findings into competitive vaccine products. I strongly believe that a well-balanced synergy between multiple scientific disciplines combined with sound strategic insights and dedicated managerial support is critical to solving complex challenges in Human and Animal Health.


Profile: Experienced management professional; expert in vaccine R&D and early vaccine dvpt,; proficiency in program and grant management; used to working in a heavily interconnected environment (in private and nonprofit sector) while managing the needs of numerous stakeholders. Proven track record of success in designing and developing vaccines, managing dynamic, high-performing consortia, developing efficient processes to deliver impact, offering expert scientific-technical advice on complex immunisation projects, leading vaccine R&D work as CSO. Proficiency in program management, team leadership, patent writing, laboratory research, immunology, epidemiology, microbiology, vaccine technologies, preclinical vaccine dvpt. Substantial experience in strategic budgeting, CMC- and IP-related matters, incl. patent infringement and litigations. Over 2 decades of professional experience working in Europe and the US in managing implementation of immune interventions to address unmet medical needs. Highly familiar with major challenges in Global Health (as previously engaged with B. & M. Gates Foundation and GAVI).


I am particularly interested in engaging with international companies or organisations in the private or public sector or which are involved in public-private partnerships targeted at translational medicine programs, preferably in the field of Vaccine Innovation or Intellectual Property (e.g., IP issues, litigations related to infringement of vaccine patents).

Newspapers

Featured Articles

Guest Videos

Guest Podcasts

You are welcome to subscribe to our newsletter only, but we do recommend that you create a user account instead which will give you access to members-only content and automatically add you to our mail list. Creating a free member account also gives you automatic notifications of new posts. Note: We will likely send out only very infrequent newsletters.

Just Subscribe to Our Newsletter

  • Bitchute Channel
  • Brand New Tube channel
  • YouTube Channel

© 2020-21 by CV19 News.

This site was designed with the
.com
website builder. Create your website today.
Start Now